← Back to Search

FM2 and LAST simultaneous for Reproductive Health

N/A
Waitlist Available
Led By Janet S St. Lawrence, Ph.D.
Research Sponsored by Portland State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

Study Summary

This trial will test whether a parent and adolescent intervention can help reduce the risk of STIs, HIV, and unintended pregnancies among young people in Botswana.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Attitudes toward Transactional Sex Scale (youth)
Change in number of sex partners (youth and parent)
Changes in Condom Barriers Scale(youth)
+8 more

Trial Design

3Treatment groups
Active Control
Group I: FM2 and LAST simultaneousActive Control2 Interventions
Parents participate in Families Matter 2 (FM2) and adolescents in Living as a Safer Teen (LAST) intervention immediately following the baseline assessment.
Group II: FM2 first, LAST delayedActive Control2 Interventions
Parent intervention, Families Matter 2 (FM2), immediate, adolescent intervention, Living as a Safer Teen (LAST), delayed six months
Group III: Comparison armActive Control2 Interventions
Comparison arm in which both parents and adolescents will be offered their respective interventions following the final assessment. Following the final assessment parents will be offered the Families Matter (FM2) intervention and youth the Living as a Safer Teen (LAST) intervention as an ethically justified service.

Find a Location

Who is running the clinical trial?

Portland State UniversityLead Sponsor
22 Previous Clinical Trials
25,959 Total Patients Enrolled
Esther S Seloilwe, Ph.D.Study DirectorUniversity of Botswana
Janet S St. Lawrence, Ph.D.Principal InvestigatorPortland State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a call for participants in this clinical investigation?

"Clinicaltrials.gov confirms that this medical study is recruiting patients, having been first posted on April 22nd 2019 and recently updated September 18th 2020."

Answered by AI

Does this study have an age restriction, and if so is it accommodating individuals over eighty-five?

"This trial seeks to include participants aged 13-80. There are additional specialised trials available for those under 18 and above 65 years old, respectively."

Answered by AI

What is the current enrollment rate for this research project?

"Affirmative. The information located on clinicaltrials.gov indicates that the trial is actively recruiting patients, having been first posted on April 22nd 2019 and last updated on September 18th 2020. This medical study requires 1000 participants from one site."

Answered by AI

What is the accepted demographic of participants in this experiment?

"The research team is actively searching for 1000 patients aged 13 to 80 with reproductive health issues, who are located in Gaborone Botswana and have a parent or guardian."

Answered by AI
~169 spots leftby Mar 2025